Table 2.
Clinical Classification Software (CCS) - PASC-related conditions deemed clinically significant by our infectious disease physicians among PCR-positive patients
| Time Period | |||
|---|---|---|---|
| CCS PASC Related Conditions | Late | Acute and persistent | Pre-existing conditions |
| Other lower respiratory disease | 2.73% | 4.50% | 10.40% |
| Diabetes | 2.25% | 1.32% | 9.85% |
| Gastrointestinal Disease | 4.19% | 1.59% | 2.89% |
| Conditions associated with dizziness or vertigo | 4.06% | 0.91% | 3.06% |
| Abdominal pain | 4.34% | 0.71% | 2.95% |
| Nonspecific chest pain | 4.17% | 1.42% | 1.61% |
| Mental health | 2.64% | 0.61% | 3.21% |
| Anxiety disorders | 2.74% | 0.86% | 2.27% |
| Genitourinary symptoms and ill-defined conditions | 3.45% | 0.46% | 1.78% |
| Malaise and fatigue | 3.42% | 1.02% | 0.84% |
| Cardiac dysrhythmias | 2.26% | 1.22% | 1.31% |
| Other nervous system disorders | 1.75% | 0.46% | 1.04% |
| Respiratory failure, insufficiency, arrest | 0.21% | 2.69% | 0.23% |
| Nausea and vomiting | 1.66% | 0.30% | 0.54% |
| Fluid and electrolyte disorders | 0.99% | 0.85% | 0.55% |
| Other nutritional, endocrine, and metabolic disorders | 1.16% | 0.17% | 0.31% |
| Anosmia | 0.73% | 0.05% | 0.01% |
Time periods were defined as follows: Late: 30-120 days post-PCR-positive test date; Acute and persistent 0-30 days post-PCR-positive test date and persisted 30-120 days; Pre-existing conditions: four years prior to PCR-positive test date